drug discovery

There are currently no FDA-approved drugs to treat vitiligo, an autoimmune disease that kills skin pigment cells. But a phase III study of a drug used to treat atopic dermatitis may be the first to get the FDA seal of approval.

COVID-19 researchers focus their studies on antibodies targeting exposed parts of SARS-CoV-2, but in a new study, a group of researchers showed that antibodies targeting proteins inside the virus are just as important for a robust immune response.

Some scientists use cancer patients as libraries for discovering novel immunotherapies.

Automated synthetic biology workflows enable efficient mRNA-based therapeutic development.

Learn how scientists integrate computational biology and experimental data to accelerate antibody drug development.

An obesity medicine clinician researcher propels a growing movement to normalize obesity as a disease that requires long-term treatment.

Membraneless droplet like organelles known as condensates are changing the way some scientists approach drug discovery.

The company plans to develop more specialized, antibody-based GPCR drugs to treat a myriad of diseases. They recruited a leader in overseeing successful clinical trials to get the job done.

LIVE March 29th, 2022 at 2:30 PM
Proteolysis targeting chimeras (PROTACs) are promising agents for developing novel anticancer drugs.

LIVE February 18th, 2022 at 10:00 AM ET
Careful study of the neurobiology of mental health leads to insights on the complexities of the human mind.